A new meta-analysis in the May 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network provides updated ...
Thousands of Americans develop chronic persistent symptoms—such as fatigue, cognitive difficulties ("brain fog"), and other ...
Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...
Influencers and others on social media have seized on the hantavirus outbreak to revive disinformation that sowed distrust ...
A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that ...
The ENO Breathe programme can improve HRQOL, breathlessness, anxiety, and respiratory symptoms in people with long COVID and ...
Ugh, in case our allergies weren't bad enough.
Exercise has been touted as a tool for managing and treating long covid, but much of the evidence has neglected one of its ...
Long COVID remains a frustrating medical mystery, affecting up to 1 in 10 people long after the initial infection fades. Now, scientists have uncovered a crucial clue hidden deep within the immune ...
A total of 399 adults with fatigue persisting 90 or more days after confirmed SARS-CoV-2 infection were enrolled in the trial. HealthDay News — For patients with postacute sequelae of SARS-CoV-2, ...
1. In this randomized controlled trial, fluvoxamine reduced fatigue, improved quality of life, and increased recovery frequency in adults with long COVID. 2. Metformin showed no significant effect on ...
Resolution of Chronic Fatigue in a Patient With Post-COVID EBV Reactivation and Mold-Related Illness
A case illustrating the interplay between EBV reactivation, environmental mold exposure, and immune dysregulation in a patient with persistent post-viral fatigue. This case report examines chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results